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Abstract
Transgenic mice expressing fluorescent proteins in specific cell populations are widely used for in vivo brain studies with
two-photon fluorescence (TPF) microscopy. Mice of the thy1GFP-M line have been engineered for selective expression of
green fluorescent protein (GFP) in neuronal populations. Here, we report that TPF microscopy reveals, at the brain surface of
these mice, also motile non-neuronal GFP+ cells. We have analyzed the behavior of these cells in vivo and characterized in
brain sections their immunophenotype. With TPF imaging, motile GFP+ cells were found in the meninges, subarachnoid
space and upper cortical layers. The striking feature of these cells was their ability to move across the brain parenchyma,
exhibiting evident shape changes during their scanning-like motion. In brain sections, GFP+ cells were immunonegative to
antigens recognizing motile cells such as migratory neuroblasts, neuronal and glial precursors, mast cells, and fibroblasts.
GFP+ non-neuronal cells exhibited instead the characteristic features and immunophenotype (CD11c and major
histocompatibility complex molecule class II immunopositivity) of dendritic cells (DCs), and were immunonegative to the
microglial marker Iba-1. GFP+ cells were also identified in lymph nodes and blood of thy1GFP-M mice, supporting their
identity as DCs. Thus, TPF microscopy has here allowed the visualization for the first time of the motile behavior of brain DCs
in situ. The results indicate that the thy1GFP-M mouse line provides a novel animal model for the study of subsets of these
professional antigen-presenting cells in the brain. Information on brain DCs is still very limited and imaging in thy1GFP-M
mice has a great potential for analyses of DC-neuron interaction in normal and pathological conditions.
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Introduction
The generation of transgenic mice expressing fluorescent
proteins in subsets of cells in the brain, such as glia, neurons,
and monocyte-derived cells, together with the increasing use of
two-photon fluorescence (TPF) microscopy have allowed in vivo
investigations of different cell types at the single cell level [1–3].
Thus, advances have been achieved in the investigation of a wide
range of phenomena such as dendritic spine remodeling after
learning/experience [4–7], stroke [8], neuroinflammation [9] and
laser dissection [10,11].
The thy1GFP-M knock-in mice express green fluorescent
protein (GFP) in about 10% of neurons. In these mice, the
regulatory element Thy1 has been modified by deletion of the
intron required for the expression of the insert gene in non-
neuronal cells [12,13]. Therefore, thy1-expressing non-neuronal
cell types (thymocytes, peripheral T cells, myoblasts, epidermal
cells, keratinocytes) [14] and dendritic cells (DCs) [15] should not
express GFP. However, in the initial description of this mouse line,
the occurrence of a few fluorescent-tagged mononucleated cells in
the brain was reported as occasional finding, though with no
details on their identification and characterization [13].
On the basis of this initial report, we here investigated whether
non-neuronal cells, and in particular immune cells, could be
detected in the brain of mice of the thy1GFP-M line. Our in vivo
scrutiny of the brain surface of thy1GFP-M mice to this purpose
was based on TPF microscopy. These analyses have revealed, in
the meninges and cerebral cortex, a population of motile GFP-
tagged cells which did not exhibit the features of mature neurons.
The present study has been focused on the investigation of such
GFP-tagged non-neuronal cells at the brain surface of thy1GFP-M
mice. The cell motile behavior was analyzed through TPF imaging
in vivo followed by immunohistochemical phenotyping in brain
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sections. Since the findings revealed the identity of these cells as
immune elements, blood and lymph nodes were also examined.
Materials and Methods
Animals
Young adult (3–6 month-old) thy1GFP-M and C57BL6J (wild-
type, WT) and L7-GFP mice were used. A colony was established
in the animal facilities at the Medical Faculty of the University of
Verona from breeding couples (kindly supplied by Dr. Joshua
Sanes, Harvard University, Boston, MA, USA). Mice were
genotyped by polymerase chain reaction (PCR) using the e-YFP-
F1 and e-YFP-R4 primers (eYFPF1: 5’ATCTTCTTCAAGGAC-
GACGGCAACTACAAG3’; eYFPR4: 5’AGAGT-
GATCCCGGCGGCGGTCACGAACTCC 3’). The amplifica-
tion product was separated by 1.8% agarose gel electrophoresis
and visualized by Syber Green staining (Sigma, Milan, Italy) under
UV light.
The animals were maintained under standard environmental
conditions (temperature, humidity, 12 h/12 h light/dark cycle,
with water and food ad libitum) under veterinarian assistance.
Animals handling and surgery were performed following a
protocol which received approval by the Animal Care and Use
Committee of the University of Verona (CIRSAL), and authori-
zation by the Italian Ministry of Health, in strict adherence to the
European Communities Council (86/609/EEC) directives, mini-
mizing the number of animals used and avoiding their suffering.
In vivo imaging
For in vivo imaging the open skull technique was performed as
previously described [16]. Briefly, the mice were deeply anesthe-
tized by ip injection of ketamine (90 mg/kg) and xylazine (9 mg/
kg). A low dose of dexamethasone (0.04 ml at 2 mg/ml) was
administered prior to surgery to minimize brain swelling. The
animals were then placed on a stereotaxic frame; a heating blanket
was used to prevent hypothermia and the eyes were protected
from dehydration by a drop of saline.
For the open skull technique, a small craniotomy was performed
under the dissecting microscope by delimiting with a dental drill
an area of about of 25 mm2, while the skull was frequently
refreshed by application of a drop of saline. The bone flap was
removed and a circular cover glass was applied to cover the dura
and sealed to the skull by cyanoacrylate mixed with dental acrylic
cement.
In 4 mice, superficial blood vessels were labeled with the red
fluorescent dye sulforhodamine 101 (SR101) by a brief application
of a 500 nM solution on the cortex before placing the optical
window [17]. In 6 mice, blood plasma was labeled through tail
vein injection of a 0.2-ml bolus of 5% (w/v) either Texas Red
dextran (70 kDa) (Invitrogen, Milan, Italy; D-1830) or tetramethyl
rhodamine isothiocyanate-conjugated dextran in saline [18,19].
Control experiments (n = 3) were also performed using the
thinned skull technique as described by Yang et al. [20].
At the end of surgery, the mice were woken up and left on the
heating blanket until recovery; dehydration was prevented by
subcutaneous injection of saline. The animals then received
antibiotic treatment (enrofloxacin, 5 g/kg, ip), and were returned
to their home cage for at least 24 h after surgery. To minimize
inflammatory phenomena that may occur after surgery, the mice
were treated daily with the anti-inflammatory drug Carprofen
(5 mg/kg, sc).
TPF imaging was performed using a custom-made, upright,
scanning microscope as previously described [10,11] or through a
Leica SP5 microscope equipped with a pulsed Ti: sapphire laser
(Chameleon, Coherent Incorporated, Santa Clara, CA) and with
an objective lens Leica HCX APO L20x/NA0.95, water
immersion. A detection system (PML-Spec, Becker &Hickl
GmbH, Berlin, Germany) constituted by a diffraction grating
and a 16-channels multi-anode photomultiplier strip was used to
acquire the fluorescence spectrum. This allows spectral resolved
(13 nm for each channel) measurements of fluorescence light with
variable spectral range.
Analysis of in vivo imaging data
In vivo TPF 3D stacks were analyzed through an open source
imaging processing software (ImageJ) and Imaris software (Bit-
Plane, Zurich, Switzerland). The Spot Analysis was used for semi-
automated tracking of cell motility in three dimensions over time.
For cell speed, the coordinates of each cell were calculated and
tracked over time. Since motion artifacts can be caused by
dendrite ‘‘probing’’, animal’s pulse and breathing, displacements
smaller than 2.0 mm/min were filtered out of the cell tracks [21].
Cells showing a displacement below the threshold of 2.0 m/min
were therefore considered as static (sessile) cells.
Histology, immunohistochemistry and confocal
microscopy on brain and cervical lymph node sections
For the ex vivo study, thy1GFP-M mice (n = 7) were deeply
anesthetized (trybromethanol, 1.25% final solution; 20 mg/kg, ip)
and transcardially perfused with 0.1 M phosphate-buffered saline,
pH 7.2 (PBS), followed by 4% paraformaldehyde in PBS. The
brain and superficial cervical lymph nodes were rapidly dissected
out and stored for cryoprotection in 30% sucrose in PBS at 4uC
until they sank. The tissue samples were then embedded in OCT
cryoembedding matrix and sectioned on the coronal plane at a
30 mm thickness (brains) or 20 mm thickness (lymph nodes) with a
cryostat or a freezing microtome.
For the immunohistochemical procedure, brain and lymph
node sections were first treated for 20 min at room temperature
with a blocking solution of 2% bovine serum albumin (BSA), 2%
normal goat serum or fetal serum and 0.2% Triton X100 in PBS,
and then incubated overnight at 4oC in primary antibodies. Brain
sections were processed with the primary antibodies listed in Table
1. Lymph node sections were processed for immunohistochemistry
with CD11c and/or CD3 primary antibodies (Table 1). After
washes in PBS, sections from all the tissue samples were incubated
with secondary antibodies for 2 h at room temperature. The
following secondary antibodies (all purchased from Invitrogen)
were used: anti-rat IgG Alexa 594; goat anti-hamster IgG Alexa
568; goat anti-mouse IgG Alexa 549; goat anti-mouse IgG Alexa
647; goat anti IgGM 350; anti IgG1 Alexa 647; anti-rabbit IgG
(H+L) Alexa 568; anti-rat IgG 594, and anti-mouse IgG1 Alexa
594. Secondary antibodies were all diluted 1:1000 in the above
blocking solution, with the appropriate serum. After immunohis-
tochemical processing, the sections were counterstained with the
fluorescent nuclear marker DAPI (4’–6’-diamidino-2-phenylin-
dole) and mounted on slides with 0.1% paraphenylendiamine in
glycerol-based medium (90% glycerol and 10% PBS).
Preliminary observations were performed to detect GFP+ non-
neuronal cells on sections from mice sacrificed after in vivo imaging
and processed (as described above) for double immunostaining
antibodies. Anti-laminin was used to visualize the pia mater, and
anti-NeuN antibody to discriminate GFP+ neurons from GFP+
non-neuronal cells. NeuN-/GFP+ cells were identified at the same
location and with the same morphology observed in vivo.
For immunohistochemical analysis and cell counts, coronal
brain sections were sampled from bregma 1.18 to bregma -2.70
(stereotaxic coordinates from [22]), collected in adjacent series of
GFP-Tagged Dendritic Cells thy1GFP-M Mice
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every fourth section. At least 75% of pia mater extent and the
choroid plexus were preserved in the collected sections, which
were otherwise discarded. To quantify the percentage of non-
neuronal GFP+ cells with respect to the total amount of major
histocompatibility complex class II (MHCII+) and CD11c+ cells, a
total of 12 brain sections were collected from four thy1GFP-M
mice. Analysis of the percentage of non-neuronal GFP+ cells
expressing MHCII and/or CD11c was performed on 18 coronal
sections from six brains. Cell counting was performed scanning
each section with the confocal microscope Leica SP5 (Leica,
Manheim, Germany) and 0.8 mm serial Z-stacks digital photo-
graphs were captured and analyzed for the colocalization of the
above markers and GFP with the software Leica Application Suite
(LAS).
Image acquisition was performed with the confocal microscope
Leica SP5. Serial Z-stack digital images (0.8 mm) were captured
and analyzed with Leica Application Suite software.
Flow cytometry analysis on whole blood
Blood samples were collected by retro-orbital venipuncture in
anesthetized mice using heparinized microcapillary tubes and used
for flow cytometric analysis as previously described [23]. Briefly,
red blood cells were lysed in lysis buffer (155 mM NH4Cl, 10 mM
KHCO3, 5% EDTA pH 7.4) 1:10 v/v for 10 minutes. White
blood cells were washed once with 1% BSA in phosphate buffer
and incubated in 1% BSA in PBS with anti-mouse CD16/CD32
(Clone 2.4G2, BD Biosciences, San Jose´, CA, USA) for 15 min, to
block Fc receptors and reduce nonspecific binding. Samples were
stained with the anti GR-1-APC (Ly-6G/Ly-6C, Clone RB6-8C5,
BD Biosciences, Mountain View, CA), CD11b APC-Cy7 (Clone
M1/70, BD Biosciences), CD8a PerCP-Cy5.5 (Clone 53-6.7,
eBioscience, San Diego, CA USA), CD4 PE-Cy7 (Clone GK1.5,
eBioscience), CD3 APC (Clone 17A2, eBioscience), CD45R/B220
APC-Cy7 (Clone RA3-6B2, BD Biosciences), F4/80 Pe-Cy7
(Clone BM8, eBioscience). All phenotypic assays of WT and
Table 1. Immunophenotypic profile of NeuN-/GFP+ cells in thy1GFP-M mice.
ANTIBODY SUPPLIER
IMMUNOGEN,
DILUTION ANTIGEN CELL TYPE
NEuN-/GFP+
CELLS
NEURONAL AND GLIAL PROGENITOR
anti-CD133 Santa Cruz Santa Cruz,CA rabbit IgG 1:500 prominin quiescent neural stemcells –
anti-NG2 Chemicon Temecula,CA rat IgG 1:500 chondroitinsulfate
proteoglycan NG2
oligodendrocyte; neural
progenitors
–
anti-O4 Millipore Billerica,MA mouse IgM 1:500 O4 pro-oligodendrocytes –
anti-A2B5 Millipore Billerica, MA mouse IgM 1:500 A2B5 oligodendrocyte progenitors –
anti-nestin Chemicon Temecula,CA mouse IgG11:200 nestin neural stemcells –
NEUROBLASTS
anti-DCx Santa Cruz Santa Cruz,CA goat IgG 1:100 doublecortin migratory neuroblasts –
anti- TUJ-1 Covance Princeton,NJ mouse IgG2a 1:500 neuronal class III-tubulin neuroblasts –
NEURONS
anti-NEuN Chemicon Temecula,CA mouse IgG1 1:200 neuronal nuclei protein neurons –
anti-GAD-67 Chemicon Temecula,CA mouse IgG1 1:1000 glutamic acid decarboxylase
67
GABAergic neurons –
anti-MAP-2 Sigma Saint Louis, MO mouse IgG1 1:1000 microtubulo associated
protein-2
neuronal dendrites –
ASTROCYTES
anti-GFAP Chemicon Temecula,CA mouse IgG1 1:500 glial fibrillary acidicprotein astrocytes –
ANTIGEN-PRESENTING CELLS
anti-MHC-II AbDSerotec Oxford, UK mouse IgG1 1:500 major histocompatibility
complex class II
dendritic cells, microglia,
macrophages
+A
anti-CD11c Biolegend San Diego CA armenian hamsterIgG
1:500
complement type 4
receptor (CR4)
subset of dendritic cells,
microglia
+A
anti-Iba-1 Santa Cruz Santa Cruz,CA rabbit IgG 1:500 ionized calcium binding
adaptor molecule 1
microglia, monocytes,
neutrophils
–
anti-CD11b AbDSerotec Oxford UK rat IgG2b 1:500 complement type
3 receptor (CR3)
subset of dendritic cells,
microglia, subset of
macrophages, natural
killer cells
+B
anti-F4/80 Acris antibodies Herdford,
Germany
rat IgG2b 1:200 F4/80 macrophages –
OTHER NON-NEURONAL CELLS
anti-avidin Chemicon Temecula,CA mouseIgG 1:500 avidin mastcells –
anti-fibronectin Acris antibodies Herdford,
Germany
mouse IgG1 1:500 fibronectin fibroblasts –
ASubset of positive cells in higher number in meninges than in choroid plexus ;BSubset of positive cells mainly round shaped and without ramifications.
doi:10.1371/journal.pone.0056144.t001
GFP-Tagged Dendritic Cells thy1GFP-M Mice
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thy1GFP-M samples were performed in parallel. Flow cytometric
analysis was performed on a FACS Canto flow cytometer (BD
Biosciences) and data were analyzed by FlowJo software version
7.6.4 (Tree Star, Ashland, OR, USA). Different cell populations
were clustered according to the presence and intensity of cell
surface epitope markers [23–25]. Debris and doublets were
excluded from the analysis based on the Side/Forward light
scattering plot and FSC-H/FSC-A plot respectively (data not
shown). GFP+ cells were arbitrarily set up to about 0.1% of the
highest negative control and then applied to all the other samples,
to include the vast majority of GFP+ cells in thy1GFP-M blood.
Single stains were used as compensation controls.
Results
In vivo observation of GFP+ cells in the meninges and at
the cortical surface of thy1GFP-M mice
TPF imaging was performed in adult thy1GFP-M mice (n = 12)
through the optical window as described above. With this
approach, the apical dendrites of GFP-tagged neurons, their
dendritic spines and apical tufts were visualized in cortical layers I
and II, together with cell bodies of pyramidal neurons residing in
layers III and neuronal elements in layer IV.
Motile green fluorescent cells with morphological features and
distribution different from those of neurons were also observed in
the TPF microscopy investigation (Figure 1). To clarify whether
the fluorescence emission of these non-neuronal cells derived from
the same fluorescent protein expressed in neurons (GFP), we
characterized in vivo the emission spectrum of the fluorescent non-
neuronal cells through a multi-channel acquisition. We found that
the fluorescence spectrum of green non-neuronal cells was
identical to the spectrum of GFP-labeled neurons (see Figure
S1). This finding suggests that the fluorescence expression in GFP-
labeled non neuronal cells may be under the control of the same
promoter (Thy-1) that targets neurons in thy1GFP-M mice [13]. In
agreement with this hypothesis, we found that in L7-GFP mice
expressing GFP on Purkinje cells under a different promoter [26],
Figure 1. In vivo observation of motile GFP-labeled cells in the cortex of thy1GFP-M mice. (A) GFP+ cell (white arrowhead) above the pial
surface rapidly changing its morphology. Time-lapse sequence of maximum intensity projections of a set of optical sections acquired at 2 mm z-step.
The right column shows the depth of the cell through a digital rotation of the corresponding images on the left. The white dotted lines indicate the
dura and pia mater.The frame acquired at 459 shows fluorescent cells (blue arrowheads) passing above the pia through the CSF. (B) GFP+ cell rolling
inside a blood vessel on the pial surface. The blood vessel walls (shown in red) were labeled by the intravital dye SR101. Fluorescent cells showing
motility at the pial surface (C) and deep in the brain parenchyma (D–E). E) GFP+ cells showing translation across the field of view. Scale bars 10 mm.
doi:10.1371/journal.pone.0056144.g001
GFP-Tagged Dendritic Cells thy1GFP-M Mice
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no fluorescent motile cells were detected during TPF imaging
experiments (n = 25).
The time-lapse TPF analysis in thy1GFP-M mice revealed that
the size and motility of GFP+ non-neuronal cells were different
depending on the region. At the most superficial level (0–15 mm
depth from the dura), in the subarachnoid space, round-shaped
GFP+ cells with a diameter of 9.9 6 1.3 mm (number of cells = 7;
number of mice = 4) were observed (Figure 1A and Movie S1)
Figure 2. Distribution of the NeuN-/GFP+ cells in the brain of thy1GFP-M mice and quantitative analyses. Confocal microscopy images
of brain sections showing non-neuronal GFP+ cells with different morphologies in the meninges. (A–D) Ramified non-neuronal GFP+ cell at the pia/
parenchyma interface visualized in bright-field in B. (E–H) Elongated non-neuronal GFP+ cell in the subarachnoid space; blood vessels and pia mater
were visualized by anti-laminin immunostaining (F, red). (I–J) Non-neuronal/GFP+ cells with ramifications or round-shaped (J), do not express the
microglial marker Iba-1 (red). The insert in I represents an high magnification of the area in the dashed box. (K–L) The glial/monocyte marker CD11b
(red) was not expressed by ramified cells in the leptomeninges (K) but is instead expressed by small-size round cells (example shown in L), which are
therefore identified as monocytes. (M–P) A non-neuronal GFP+ cell in the meninges covering the optic tract (cell nuclei are stained with DAPI, blue).
This cell exhibits the morphological features of a migratory dendritic cell, whose cytoplasmic organization in a ‘‘veil-like’’ structure provides a more
efficient motility (veiled cell); the immunopositivity to dendritic markers CD11c (N, red) and major histocompatibility complex class II (O, magenta),
together with its morphology, confirms the identity of dendritic cell. Scale bars 20 mm. The graph shows the percentage of GFP+ cells
immunopositive to anti-MHCII, anti CD11c or both these markers. Data were obtained from 83 and 118 of GFP+ cells counted in 6 animals in
meninges and choroid plexus, respectively.
doi:10.1371/journal.pone.0056144.g002
GFP-Tagged Dendritic Cells thy1GFP-M Mice
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laying on the pia mater or floating in the CSF. At the same depth,
these cells were found inside meningeal blood vessels as well,
passively transported in the blood stream; GFP+ cells rolling on
the endothelial surface of blood vessel walls were also occasionally
observed (Figure 1B and Movie S2).
At the interface between pia mater and brain parenchyma
(depth: 15–25 mm), most of the non-neuronal GFP+ cells were
round-shaped (diameter of 8.0 6 1.0 mm; number of cells = 12;
number of mice = 6) and static with average displacements
smaller than 2.0 mm/min. In this region a few GFP+ non-
neuronal cells exhibited an irregular shape and a dynamic
behavior. Most of the GFP+ cells observed within the cortical
tissue (depth: 25–60 mm from the pia) were characterized by fast
remodeling of their shape (in a time scale of minutes), with
continuous extensions and retractions of their processes (Figure 1).
Changes in morphology were accompanied in some instances by
translation of the center of the cell body mass with displacement
speeds higher than 2.0 mm/min (Figure 1 E and Movie S3). This
motile behavior appeared related to a scanning motion in the
brain parenchyma. The thinned skull preparation surgery, a less
invasive surgical approach in which the bone flap is not removed
but just reduced to a thin layer, confirmed the presence of GFP+
non-neuronal cells which exhibited the same motile behavior
observed through the chronic cranial window (Movie S4). This
indicates that in the open skull window preparation the occurrence
of GFP+ motile cells was not related to potential inflammatory
responses to the surgical approach.
Phenotypic and quantitative characterization of GFP+
cells in the meninges and choroid plexus of thy1GFP-M
mice
The phenotype of GFP+ cells and their distribution were
analyzed in fixed brain sections, thus including regions not
accessible during in vivo imaging sessions. GFP+ cells were
distinguished from neurons on the basis of their immunonegativity
to the antibody against neuron-specific protein NeuN (Table 1).
The pia mater and blood vessel walls were visualized by laminin
immunofluorescence or under bright-field observation to ascertain
the distribution of NeuN-/GFP+ cells with respect to these
structures. In line with in vivo observations, NeuN-/GFP+ cells
were observed along the meninges covering the cerebral cortex, at
the pia/cortical parenchyma interface (Figure 2 A–D) as well as
above the pia mater, in the subarachnoid space (Figure 2 E–H).
These cells were mostly associated with meningeal blood vessels, in
the perivascular space or in close association with the endothelium.
NeuN-/GFP+ cells were also found in the meninges covering the
interhemispheric fissure and in the choroid plexus. With the
exception of cells within blood vessels and in the choroid plexus,
which exhibited round/ovoid shape (8–14 mm in diameter), most
NeuN-/GFP+ cells showed an elongated shape, with a long axis
ranging from 16 mm to 22 mm.
The dynamic behavior of these cells documented in the in vivo
experiments led us to investigate their immunophenotype with
markers recognizing motile cells in the adult brain (see Table 1).
Confocal microscopy analyses on cryosections ruled out the nature
of these cells as migratory neuroblasts, stem cells, neuronal and
glial common progenitors. Furthermore, NeuN-/GFP+ cells were
immunonegative to avidin and fibronectin, markers for mast cells
and fibroblasts, respectively, which are also able to move in the
brain or at its surface. NeuN-/GFP+ cells did not express positivity
to glial fibrillary acidic protein, which ruled out their identity as
astrocytes. Moreover, these cells were immunonegative for the
microglial/macrophages antigen Iba-1, regardless of their locali-
zation and morphology (Figure 2 I–J). NeuN-/GFP+ cells were
occasionally observed (about one cell per section) in the meninges.
They exhibited a diameter ranging from 5 to 9 mm and
immunopositivity to the CD11b antigen, expressed not only by
microglial cells but also by neutrophils and monocytes (Figure 2
K–L). The majority (more than 60%) of the NeuN-/GFP+ cells
identified in the meninges expressed MHC II, thus indicating that
they were antigen-presenting cells (Figure 2 M–P and graph). On
this basis, markers of macrophages and DCs, which can act as
motile antigen-presenting cells in the brain, were tested (see Table
1). NeuN-/GFP+ cells in the meninges and choroid plexus did not
express F4/80, the most common marker of macrophages [27],
and expressed CD11c, a marker for DCs [28].
Taken together these results indicate that the immunopheno-
type of NeuN-/GFP+ cells was MHCII+/CD11c+/CD11b+/
Iba1-/F4/80-, and they could therefore be identified as DCs.
Importantly, in agreement with this characterization, we also
occasionally observed GFP+/CD11c+/MHCII+ cells with a
cytoskeletal arrangement typical of migratory DCs (veiled cells,
Figure 2 M–P) [29].
Cell counts were performed in the meninges and choroid
plexus, where NeuN-/GFP+ cells were mostly observed, to
evaluate the proportion of GFP+ DCs with respect to the entire
Figure 3. Immunophenotypic analysis of the non-neuronal
GFP-tagged cells in the brain of thyGFP-M mice. Confocal images
of coronal brain sections showing non-neuronal GFP+ cells in several
locations. (A–C) GFP+ cell into the lumen of a blood vessel (arrowhead)
in layer II of the parietal cortex. Neuronal nuclei were stained with anti-
NeuN, (B, C, red); the blood vessel is visualized in bright-field (insert A,
C). The inset in A represents the area shown an high magnification in A–
C. (D–F) GFP+ cell in the ependyma between hippocampus and
thalamus. This cell is immunopositive to the dendritic cell marker anti-
CD11c (E, red). Cell nuclei are stained with DAPI in F and represented in
blue. (G–I) In the anterior hypothalamus a high number of small-sized
GFP+ cells shows immunopositivity to the lymphocytes marker CD3+.
Different morphologies of GFP+/CD3+ cells in the anterior hypothala-
mus. A small round (H, high magnification) GFP+/CD3+ cell and a GFP+/
CD3+ cell showing an irregular shape (I, high magnification). Scale bars
10 mm.
doi:10.1371/journal.pone.0056144.g003
GFP-Tagged Dendritic Cells thy1GFP-M Mice
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Figure 4. Cytofluorimetric analysis of GFP expression in blood cells from WT and thy1GFP-M mice. (A) GFP expression was evaluated in
monocytes as CD11b positive, GR-1 (Ly6C, Ly6G) intermediate, F4/80 positive cells (CD11b+ GR1int F4/80+); in granulocytes as CD11b positive, GR-1
highly positive cells (CD11b+ GR1high); in dendritic cells as CD11b positive, GR-1 negative, F4/80 negative, CD11c positive cells (CD11b+ GR1- F4/80-
GFP-Tagged Dendritic Cells thy1GFP-M Mice
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DCs population (MHCII+/CD11c+) and the proportion of GFP+
cells expressing MHCII or CD11c, respectively. This part of the
study indicated that GFP+ DCs represented 10.30 6 3.85% of
DCs in the meninges and 13.08 6 4.30% of DCs in the choroid
plexus. With respect to either marker, in the meninges GFP+/
MHCII+ cells accounted for 7.12 6 0.21% of the MHCII+ cell
population, and GFP+/CD11c+ cells for 9.19 6 3.15% of the
CD11c+ cell population. In the choroid plexus, GFP+/MHCII+
represented 6.80 6 1.61% of MHCII+ cells, and GFP+/CD11c
represented 15.04 6 8.32% of CD11c+ cells.
Quantitative analysis of the phenotype of GFP+ cells was then
pursued. In the meninges about 83% of GFP+ cells were identified
by the expression of MHCII and/or CD11c (GFP+/MHCII+/
CD11c+ 31.82 6 6.88%; GFP+/MHCII+/CD11c- 32.37 6
7.66%; GFP+/MHCII-/CD11c+ 18.716 7.15%) (Figure 2 Q). In
the choroid plexus, about 40% of GFP+ cells were identified with
the same markers (GFP+/MHCII+/CD11c+ 10.75 6 6.48%;
GFP+/MHCII+/CD11c- 17.776 7.02%; GFP+/MHCII-/
CD11c+ 14.816 5.16) (Figure 2 Q).
Distribution of NeuN-/GFP+ cells in the brain of thy1GFP-
M mice
At the examination in confocal microscopy, NeuN-/GFP+ cells
with different morphologies and sizes were observed in the brain
parenchyma. In layers I and II of the parietal cortex NeuN-/GFP+
cells with thin ramifications were found to be associated with the
abluminal side of blood vessel walls. In the same area, a few round-
shaped cells, 6–8 mm in diameter, were observed inside the lumen
of blood vessels (Figure 3 A-C). NeuN-/GFP+ cells were observed
in layer II of the piriform cortex and in the corpus callosum and in
circumventricular organs. In particular, in the subfornical
organGFP+ cells exhibited a peculiar morphology, with elongat-
ed/stellate or elongated/dendriform shape and multiple ramifica-
tions. Ramified NeuN-/GFP+ cells were also found in
the subventricular zone and in the molecular layer of the
hippocampus. In the ependyma, a few GFP+ cells were identified
(Figure 3 D–F).
In addition, GFP-labeled NeuN- cells intensely GFP-labeled
were observed in the medial thalamus and in the anterior
hypothalamus (in particular in the premammillary nucleus), and in
the arcuate nucleus. Only in these regions, most of NeuN-/GFP+
cells were CD3 immunopositive, without ramifications and very
small (3–6 mm in diameter), indicating their nature of lymphocytes
(Figure 3 G–I).
GFP+ cells are present in the blood and cervical lymph
nodes of thy1GFP-M mice
To further confirm the identity of NeuN-/GFP+/MHC-II+/
CD11c+/CD11b+/Iba1-/F4-80- cells as DCs, the occurrence of
these cells was verified in anatomical districts in which DCs are
normally present, i.e. blood and cervical lymph nodes.
GFP expression was evaluated on blood cells by FACS analysis.
We found that 1.23 6 0.18% of the CD11b-positive, GR-1 high
positive cells (CD11b+GR-1high, granulocytes) were GFP-positive
(Figure 4 A). To detect monocytes and myeloid DCs, we used a
panel of antibodies to better cluster the two cell types, as previously
reported [23,24]. Monocytes are CD11b-positive, F4/80-low
positive and low/intermediate positive for GR-1 (CD11b+ GR-
1int F4/80+) [23] while myeloid DCs are CD11b-positive, CD11c-
positive and F4/80-negative, GR-1-negative (CD11b+
CD11c+GR-1-F4/80- Figure 4 A) [24]. We found 3.13 6 1.52%
monocytes and 3.19 6 1.49% DCs GFP-positive (Figure 4 A).
We then evaluated GFP positive cells in the lymphocyte
populations [25]. We found 0.34 6 0.21% of the B220-positive,
CD3-negative population (B220+CD3-, B lymphocytes), 0.34 6
0.11% of the CD3, CD4-positive, B220, CD8-negative population
(CD3+B220+CD4+CD8-, T Helper) and 0.59 6 0.16% of the
CD3, CD8-positive, B220, CD4-negative population
(CD3+B220-CD4-CD8+, T Cytotoxic) (Figure 4 B). As shown in
Figure 4 the distribution of GFP fluorescence span over three
order of magnitude of intensity suggesting different levels of
expression in blood cells [30].
GFP-labeled cells were found in lymph nodes (Figure 5), where
they exhibited the typical morphological features of DCs, with
long membrane extensions, and were mainly observed around the
CD11c+). (B) Lymphocyte population were phenotypically characteryzed as B220 positive, CD3 negative cells (B lymphocytes, B220+ CD3-); B220
negative, CD3 positive, CD8 positive, CD4 negative cells (T cytotoxic cells, B220- CD3+ CD8+ CD4-) and B220 negative, CD3 positive, CD8 negative, CD4
positive (T helper, B220- CD3+ CD8- CD4+). Percentages inside the gates represent positive cells of parent populations. The figures shown are a
representative experiment of 3 other separate experiments from 3 different mice performed with similar results.
doi:10.1371/journal.pone.0056144.g004
Figure 5. GFP-DCs in cervical lymph nodes of a thy1GFP-M mouse. (A) Confocal analysis of cryosectioned cervical lymph node shows the
presence of numerous GFP-tagged cells (green). They surround the B cell follicles (dashed lines) and extend in the T cell zone (on the upper right of
the figure), while they rarely occur in the subcapsular zone. CD3+ cells, visualized by immunohistochemistry, are here shown in red. (B) High
magnification of CD3+ cells (red) and GFP+ cells (green) in the T cell zone. (C) Immunopositivity of GFP-tagged cells (green) to CD11c (red; white
arrowheads). Note that the GFP is expressed in the cytoplasm of GFP+DCs.
doi:10.1371/journal.pone.0056144.g005
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B cell follicles and extended into the T cell zone, rarely occurring
in the subcapsular zone (Figure 5 A). They showed immunopo-
sitivity to anti-CD11c, which thus confirmed their identity as DCs
(Figure 5 C).
Discussion
The present investigation shows that in thy1GFP-M mice,
engineered to express GFP in neurons, a GFP-tagged monocyte-
derived cell population is observed in the meninges, perivascular
space, choroid plexus, as well as in brain tissue. These cells show
the morphological features, motile behavior, and antigen expres-
sion which characterize DCs, and are Iba-1-immunonegative and
therefore distinct from microglial cells. GFP+ DCs have also been
here identified in cervical lymph nodes and blood of thy1GFP-M
mice, in agreement with their identity as DCs.
Our imaging analysis with TFP has allowed detection of GFP-
tagged brain DCs in thy1GFP-M mice in vivo and we here show for
the first time their motile behavior. Such sets of data are discussed
below.
Brain dendritic cells visualized in vivo in thy1GFP-M mice
DCs are professional antigen-presenting cells which modulate
the delicate balance between induction and suppression of
immune response by self or no-self antigen presentation to T cells
[31,32]. DCs are equipped with the most potent antigen-
presenting capacity among all immune cells [33].
DCs are well characterized in peripheral organs, especially in
lymph nodes, where antigen presentation mainly occurs. In the
CNS, these cells are strategically located at the interface between
blood/cerebral parenchyma (subarachnoid space), CSF/cerebral
parenchyma (meninges, ependyma), CSF/blood (choroid plexus),
suggesting an immunosurveillance function for brain DCs as well
[34]. However, their role in the immune-specialized CNS remains
elusive and, as recently emphasized, DCs are the least explored
among leukocytes which can be recruited to the CNS [33].
In vivo imaging has here allowed the observation for the first
time of the motile behavior of brain DCs in situ. They were found
to be mainly sessile in the meninges, and in probing motion in the
cortical parenchyma. We could thus observe GFP-DCs in a
scanning-like motion in vascular-rich brain regions, at the brain
surface of thy1GFP-M mice, in agreement with a role of
immunosurveillance of the healthy brain [31,34,35]. A similar
motile behavior has been previously described in vivo by TPF
microscopy in inguinal lymph nodes of healthy eYFP-CD11c
mice, in which CD11c is tagged with the enhanced yellow
fluorescent protein [21].
It has been shown in healthy rats that DCs, after intracer-
ebroventricular injection, can reach the cervical lymph nodes via
the CSF. Therefore, the CSF represents the major transport route
for DCs circulating in the CNS and migrating either from CSF to
brain or from CSF to lymphoid organs in physiological conditions
[36]. In agreement with these findings, in thy1GFP-M mice GFP+/
CD11c+ cells also reside in cervical lymph nodes. In addition,
migratory DCs can undergo evident cytoskeletal rearrangement
for efficient motility to cervical lymph nodes, and are therefore
indicated as veiled cells [29]. It is interesting to note that we here
observed this peculiar morphology of GFP+ cells in the meninges
of thy1GFP-M mice.
Characterization of DCs
DCs are a heterogeneous class of cells and their identification
and distinction from other cell types, in particular from
macrophages, is highly debated [37]. Indeed, myeloid lineage
markers, co-stimulatory molecules and antigens expressed by DCs
recognize only subsets of these cells and/or are expressed also
from other cell types [38]. It has also been proposed that DCs and
macrophages represent the continuum of a common progenitor
[39].
The most widely used marker for DCs is currently provided by
CD11c, which, however, is not sufficient for unequivocal
identification of these cells (see for review [37,40]). Thus, a
multiple immunophenotyping approach is required to identify
DCs. Our multilabeling strategy has shown that the non-neuronal
GFP-tagged cells which occur in the meninges of thy1GFP-M mice
are CD11c+/CD11b+/MHC-II+/F4/80- and can therefore be
identified as DCs on the basis of their currently accepted
immunophenotype [37].
The quantitative analysis in the meninges and choroid plexus of
thy1GFP-M mice has revealed heterogeneity in the expression of
MHCII and CD11c markers in DCs. Such heterogeneity was also
shown in previous studies of DCs in the rat choroid plexus [41]
and in whole mount preparations of the rat meninges [42,43].
Quantitative analyses of putative DCs in the meninges and
choroid plexus have been recently reported in Itgax/eYFP/
CD11c transgenic mice [44]. In this murine line, eYFP labels all
CD11c+ cells, including Iba1+ cells, in the meninges and brain
parenchyma [21,44,45]. In wholemount preparation of the dura
mater, pia/arachnoid and choroid plexus, the entire population of
eYFP/CD11c+ cells co-expressed Iba1 and MHCII [44]. Similar
results were also obtained by immunophenotypical analyses on
brain sections in CD11c diphtheria toxin receptor-GFP mice,
raising the issue that fluorescent CD11c+ cells could represent a
subclass of microglial cells rather than DCs [46]. This uncertainty
does not apply to thy1GFP-M mice, in which no GFP+/Iba-1+
cells were identified, indicating that microglial cells do not express
GFP in these mice.
Moreover, we found that, regardless of GFP expression, only a
percentage of CD11c+ cells co-expressed MHCII (about 20% in
the meninges and about 40% in the choroid plexus). It is possible
that, as previously suggested [45], immunohistochemistry could be
a less sensitive technique than genetic modification. On the other
hand, gene insertion could be not entirely selective for a given cell
population. As further confirmation of the identity of GFP+ cells as
dendritic or monocyte-derived population of cells in thy1GFP-M
mice, FACS analysis showed that these cell populations represent
the highest percentage of GFP+ cells in whole blood.
Conclusions
The present findings indicate that the thy1GFP-M mice provides
a novel animal model for in vivo investigations of brain DCs. It has
been recently stated that the recruitment of DCs into the brain by
TPF microscopy remains to be explored [33]. The simultaneous
visualization of fluorescently labeled neurons and DCs in thy1GFP-
M mice could now allow this type of investigation as well as the
study of other key aspects of neural-immune interactions.
Supporting Information
Figure S1 Comparison of fluorescence spectra of neu-
ronal and non-neuronal cells in thy1GFP-M mice. The
plot shows the similarity of the fluorescence spectra acquired in
neuronal cells (empty circle) and non-neuronal cells (full circle).
(TIF)
Figure S2 Percentage of GFP positive cells in thy1GFP-
M mouse blood cell populations. Granulocytes (CD11b+
GR1high), monocytes (CD11b+ GR1int F4/80+), dendritic cells
(CD11b+ GR1- F4/80- CD11c+), B lymphocytes (B220- CD3-), T
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cytotoxic cells (B220- CD3+ CD8+ CD4-) and T helper (B220-
CD3+ CD8- CD4+). Data are presented as means 6 SD (n= 3).
(TIF)
Movie S1 Motile non-neuronal GFP+ cell at pial level. In
vivo TPF microscopy movie of a non-neuronal GFP+ cell in the
cortex of a thy1GFP-M mouse showing evident changes of shape
over 55 minutes. On the top-right corner of the field, a faintly
GFP+ moving cell is also visible. At minute 25 a fluorescent cell
suddenly appears, suggesting a floating motion in the cerebrospi-
nal fluid. Each frame is a maximum intensity projections of a set of
optical sections acquired at 2 mm z-step.
(AVI)
Movie S2 Non-neuronal GFP+ cell rolling inside a blood
vessel. In vivo TPF microscopy movie of a non-neuronal GFP+
cell (green) rolling inside a blood vessel (red). The vessel wall was
visualized using the intravital dyeSR-101. Each frame is a
maximum intensity projections of a set of optical sections acquired
at 2 mm z-step.
(AVI)
Movie S3 Translating non-neuronal GFP+ cell inside the
brain parenchyma. In vivo TPF microscopy movie of a non-
neuronal GFP+ cell translating across the field. Each frame is a
maximum intensity projections of a set of optical sections acquired
at 2 mm z-step.
(AVI)
Movie S4 Motile non-neuronal GFP+ cells observed
through the thinned skull surgery. In vivo TPF microscopy
movie of non-neuronal GFP+ cells in a thy1GFP-M mouse in
which the skull was thinned out (see section 2.2). GFP+ cells show
the same motility observed in the open skull preparation,
indicating that surgery did not affect the behavior of these cells.
On the left, a GFP+ cell in a probing motion; in the center, a
GFP+ cell in a scanning motion on the cortical surface; at minute
10, a GFP+ cell appears for one only frame and is probably
floating in the cerebrospinal fluid. Each frame is a maximum
intensity projections of a set of optical sections acquired at 2.5 mm
z-step. Image depth: 73 mm from dura mater. Blood vasculature is
visualized by iv injected tetramethyl rhodamine isothiocyanate-
conjugated dextran.
(AVI)
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